| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 201848 | NDA | DELCATH SYSTEMS INC | 001 | HEPZATO | POWDER;INTRA-ARTERIAL | EQ 50MG BASE/VIAL | MELPHALAN HYDROCHLORIDE | 2023-08-14 | Prescription | Yes |